Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11530386 Cells expressing recombinant growth factor receptors

Overview Structured Data Issues Contributors Activity

Is a

Date Filed

December 15, 2016

Date of Patent

December 20, 2022

Patent Application Number

16061435

Patent Citations

US Patent 10272113 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10363273 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10398734 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10415015 Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

US Patent 10420799 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10463697 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10517894 Restimulation of cryopreserved tumor infiltrating lymphocytes

US Patent 10533156 Methods of cell culture for adoptive cell therapy

US Patent 10537595 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10639330 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

•••

Patent Citations Received

US Patent 12116564 Cells expressing recombinant growth factor receptors

0

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Primary Examiner

Christopher M Babic

CPC Code

Find more entities like US Patent 11530386 Cells expressing recombinant growth factor receptors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.